《Stroke & Vascular Neurology》

作品数：485被引量：2863H指数：24
导出分析报告
《Stroke & Vascular Neurology》
主办单位：中国卒中学会
最新期次：2024年6期更多>>
发文主题：PATIENTSSTROKEACUTECEREBRALPREVENTION更多>>
发文领域：医药卫生自动化与计算机技术文化科学理学更多>>
发文基金：国家自然科学基金国家重点基础研究发展计划北京市自然科学基金上海市自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Design of trials in lacunar stroke and cerebral small vessel disease:review and experience with the LACunar Intervention Trial 2(LACI-2)
《Stroke & Vascular Neurology》2024年第6期581-594,共14页Gordon Blair Jason P Appleton Iris Mhlanga Lisa J Woodhouse Fergus Doubal Philip M Bath Joanna M Wardlaw 
Alzheimer Society UK.UK Dementia Research Institute(DRIEdi17/18MRC MC_PC_17113);British Heart Foundation(CS/15/5/31475);The Stroke Association.Mrs Gladys Row Fogo Charitable Trust(AD.ROW4.35D.FID3668413);Fondation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces.Alzheimer’s Research UK.UK Medical Research Council.
Cerebral small vessel disease(cSVD)causes lacunar stroke(25%of ischaemic strokes),haemorrhage,dementia,physical frailty,or is‘covert’,but has no specific treatment.Uncertainties about the design of clinical trials i...
关键词：NARROW RETENTION MISSING 
Risk stratification of delayed causative aneurysm detection and long-term outcome in angiographically negative spontaneous subarachnoid haemorrhage被引量：1
《Stroke & Vascular Neurology》2024年第6期595-603,共9页Jie Wang Jian-Feng Meng Shuo Wang Ji-Zong Zhao Yong Cao 
National Natural Science Foundation of China(grant no.82171267);National Key Research and Development Program of China(grant no.2021YFC2501102).
Background The risk factors of aetiology and poor outcome in angiographically negative subarachnoid haemorrhage(anSAH)were unclearly.Methods The authors performed a retrospective review of a prospectively maintained d...
关键词：ANEURYSM GLASGOW STRATIFICATION 
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke:a secondary analysis of the AcT randomised clinical trial
《Stroke & Vascular Neurology》2024年第6期604-612,共9页Radhika Nair Nishita Singh Mahesh Kate Negar Asdaghi Robert Sarmiento Fouzi Bala Shelagh B Coutts MacKenzie Horn Alexandre Y Poppe Heather Williams Ayoola Ademola Ibrahim Alhabli Faysal Benali Houman Khosravani Gary Hunter Aleksander Tkach Herbert Alejandro Manosalva Alzate Aleksandra Pikula Thalia Field Anurag Trivedi Dar Dowlatshahi Luciana Catanese Ashfaq Shuaib Andrew Demchuk Tolulope Sajobi Mohammed A Almekhlafi Richard H Swartz Bijoy Menon Brian H Buck 
Background In ischaemic stroke,minor deficits(National Institutes of Health Stroke Scale(NIHSS)≤5)at presentation are common but often progress,leaving patients with significant disability.We compared the efficacy an...
关键词：ACUTE MINOR analysis 
Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke:subgroup analysis of the TRACE-2 randomised controlled clinical trial
《Stroke & Vascular Neurology》2024年第6期613-622,共10页Shuya Li Runqi Wangqin Yuesong Pan Aoming Jin Hao Li Lee H Schwamm Marc Fisher Bruce C V Campbell Mark W Parsons Ziran Wang Hongguo Dai Deyang Li Runhui Li Junhai Wang David Wang Yilong Wang Xingquan Zhao Zixiao Li Huaguang Zheng Yunyun Xiong Xia Meng Yongjun Wang 
National Natural Science Foundation of China(81870905,U20A20358,82111530203);Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(2019-I2M 5-029);The National Science and Technology Major Project(2017ZX09304018).
Background The benefit of intravenous alteplase in acute ischaemic stroke(AIS)is time-dependent.Tenecteplase is non-inferior to alteplase among patients with AIS.We aimed to delineate the association of the stroke ons...
关键词：INTRAVENOUS clinical treatment 
Gut Microbiome and Stroke:a Bidirectional Mendelian Randomisation Study in East Asian and European Populations
《Stroke & Vascular Neurology》2024年第6期623-630,共8页Shiyao Cheng Hao Zheng Yuandan Wei Xingchen Lin Yuqin Gu Xinxin Guo Zhe Fan Hao Li Si Cheng Siyang Liu 
National Key R&D Program of China(2022YFC2502400,2022YFC2502402,2022YFE0209600);National Natural Science Foundation of China(82101359,82111530203,U20A20358,31900487);Capital's Funds for Health Improvement and Research(2020-1-2041);Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(2019-I2M-5-029).
Background and aims Observational studies have implicated the involvement of gut microbiome in stroke development.Conversely,stroke may disrupt the gut microbiome balance,potentially causing systemic infections exacer...
关键词：prevention INVOLVEMENT holds 
Prediction of futile recanalisation after endovascular treatment in acute ischaemic stroke:development and validation of a hybrid machine learning model被引量：2
《Stroke & Vascular Neurology》2024年第6期631-639,共9页Ximing Nie Jinxu Yang Xinxin Li Tianming Zhan Dongdong Liu Hongyi Yan Yufei Wei Xiran Liu Jiaping Chen Guoyang Gong Zhenzhou Wu Zhonghua Yang Miao Wen Weibin Gu Yuesong Pan Yong Jiang Xia Meng Tao Liu Jian Cheng Zixiao Li Zhongrong Miao Liping Liu 
National Natural Science Foundation of China(82001920,82071301,81820108012);Beijing Municipal Administration of Hospitals’Youth Programme(QML20210503).
Background Identification of futile recanalisation following endovascular therapy(EVT)in patients with acute ischaemic stroke is both crucial and challenging.Here,we present a novel risk stratification system based on...
关键词：DATABASE PREDICTION OPTIMAL 
Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol Ⅱ(TASTE-2):a multicentre randomised controlled trial被引量：2
《Stroke & Vascular Neurology》2024年第6期730-737,共8页Chunjuan Wang Hong-Qiu Gu Qiang Dong Anding Xu Ning Wang Yi Yang Feng Wang Yongjun Wang 
Simcere Pharmaceutical Group,the Ministry of Science and Technology of the People’s Republic of China(2022YFC2504902,2022YFC2504904);National Natural Science Foundation of China(81801152,92046016);CAMS Innovation Fund for Medical Sciences(2019-I2M 5-029);Beijing Municipal Committee of Science and Technology(Z201100005620010,Z211100002921064).
Background Edaravone dexborneol is believed to be a novel cytoprotective drug,demonstrating a synergistic combination of antioxidative and anti-inflammatory properties in animal models.The Treatment of Acute Ischaemic...
关键词：protective CENTRE RANDOM 
Recurrent intracerebral haemorrhages as main manifestations in cerebral amyloid angiopathy-related inflammation被引量：1
《Stroke & Vascular Neurology》2024年第6期738-740,共3页Ya Su Yi Dong Xin Cheng 
Funding Brain Science and Brain Diseases Youth Innovation Program of Shanghai Zhou Liangfu Medical Development Foundation.
Cerebral amyloid angiopathy-related inflammation(CAA-ri)is a relatively rare and treatable subtype of CAA.We have herein reported a case of CAA-ri with repeated recurrent lobar haemorrhages within a short time as the ...
关键词：INFLAMMATION AMYLOID CEREBRAL 
Chinese Stroke Association guidelines on emergency stroke unit
《Stroke & Vascular Neurology》2024年第6期741-745,共5页Jing Jing Xuewei Xie Xinyi Leng David Wang Yongjun Wang The Emergency Stroke Unit Alliance,Chinese Stroke Association 
Organised stroke care has become a keystone in delivering efficient and effective treatment to patients with stroke with improved outcomes.Delivering timely acute reperfusion therapy to those with acute ischaemic stro...
关键词：ACUTE DIAGNOSIS treatment 
Intracerebral haemorrhage in patients taking different types of oral anticoagulants:a pooled individual patient data analysis from two national stroke registries
《Stroke & Vascular Neurology》2024年第6期640-651,共12页Bernhard M Siepen Elisabeth Forfang Mattia Branca Boudewijn Drop Madlaine Mueller Martina B Goeldlin Mira Katan Patrik Michel Carlo Cereda Friedrich Medlin Nils Peters Susanne Renaud Julien Niederhauser Emmanuel Carrera Timo Kahles Georg Kägi Manuel Bolognese Stephan Salmen Marie-LuiseMono Alexandros A Polymeris Susanne Wegener Werner Z'Graggen Johannes Kaesmacher Michael Schaerer Biljana Rodic Espen Saxhaug Kristoffersen Kristin T Larsen Torgeir Bruun Wyller Bastian Volbers Thomas R Meinel Marcel Arnold Stefan T Engelter Leo H Bonati Urs Fischer Ole Morten Rønning David J Seiffge 
Background We investigated outcomes in patients with intracerebral haemorrhage(ICH)according to prior anticoagulation treatment with Vitamin K antagonists(VKAs),direct oral anticoagulants(DOACs)or no anticoagulation.M...
关键词：PATIENTS MORTALITY treatment 
全选清除导出
共49页<12345678910>
检索报告 对象比较 聚类工具 使用帮助 返回顶部